A public health timeline to prepare for COVID-19 vaccines in Canada

For control of COVID-19, community immunity is required, necessitating widespread immunization. COVID-19 vaccines are coming to Canada, with the government announcing in August 2020 agreements with four different companies for their COVID-19 vaccine if their trials are successful. Never before has public health had to rapidly develop a vaccine introduction program for multiple new but differing vaccines with the added pressure that the program is needed across all ages and in all Canadian communities and there is high probability of not enough vaccine to go around at the start. Traditional public health vaccine introduction planning will need to be both accelerated and more comprehensive to ensure optimal uptake across the country. This overview highlights a number of points for consideration by public health in their planning for COVID-19 vaccines before these COVID-19 vaccines are available, once they are available, once supplies are plentiful, and throughout the vaccine program. Targeted and tailored communications are key elements needed to reach and positively influence diverse communities, regions, ages, languages, education levels and lived experiences.

[1]  J. Comeau,et al.  COVID-19 and missed routine immunizations: designing for effective catch-up in Canada , 2020, Canadian Journal of Public Health.

[2]  W. Cornwall.  Officials gird for a war on vaccine misinformation. , 2020, Science.

[3]  L. Hampton.  Vaccine handling and administration errors should be addressed to improve vaccine program safety. , 2020, Vaccine.

[4]  A. Usher.  COVID-19 vaccines for all? , 2020, The Lancet.

[5]  L. Barreiro,et al.  Herd Immunity: Understanding COVID-19 , 2020, Immunity.

[6]  T. Inglesby,et al.  Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic , 2020, Vaccine.

[7]  N. Lurie,et al.  Developing Covid-19 Vaccines at Pandemic Speed. , 2020, The New England journal of medicine.

[8]  Marie Hattingh,et al.  A Systematic Review on Fake News Themes Reported in Literature , 2020, I3E.

[9]  M. Gold,et al.  Immunization stress-related response - Redefining immunization anxiety-related reaction as an adverse event following immunization. , 2020, Vaccine.

[10]  È. Dubé,et al.  Optimizing communication material to address vaccine hesitancy. , 2020, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[11]  È. Dubé,et al.  Promoting immunization resiliency in the digital information age. , 2020, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[12]  W. Organization.  WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination, 14 September 2020 , 2020 .

[13]  N. MacDonald,et al.  Lessons on causality assessment and communications from the 2019 South-East Asia Regional (SEAR) workshop on inter-country expert review of selected Adverse Events Following Immunization (AEFI) cases. , 2020, Vaccine.

[14]  Abigail A. Scholer,et al.  Exploring the effect of risk and benefit information provision on vaccination decision-making. , 2019, Vaccine.

[15]  C. Betsch,et al.  Effective strategies for rebutting science denialism in public discussions , 2019, Nature Human Behaviour.

[16]  Manish M Patel,et al.  Influenza Vaccine Effectiveness. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Graham,et al.  Technologies of trust in epidemic response: openness, reflexivity and accountability during the 2014–2016 Ebola outbreak in West Africa , 2019, BMJ Global Health.

[18]  È. Dubé,et al.  Motivational interviewing: A promising tool to address vaccine hesitancy. , 2018, Vaccine.

[19]  N. MacDonald,et al.  Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017 , 2018, Vaccine.

[20]  P. Bahri,et al.  Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators , 2018, British journal of clinical pharmacology.

[21]  L. Dickinson,et al.  Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial , 2018, JAMA pediatrics.

[22]  S. Trottier,et al.  Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network). , 2018, Vaccine.

[23]  Nidhi Trivedi,et al.  Improving human papilloma virus vaccination rates throughout military treatment facilities. , 2018, Vaccine.

[24]  S. Lewandowsky,et al.  Inoculating against misinformation , 2017, Science.

[25]  N. MacDonald,et al.  Canada's eight-component vaccine safety system: A primer for health care workers. , 2017, Paediatrics & child health.

[26]  N. MacDonald,et al.  Canada's eight-component vaccine safety system: A primer for health care workers. , 2017, Paediatrics & child health.

[27]  S. Halperin,et al.  Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network , 2016, The Pediatric infectious disease journal.

[28]  J. Farrar,et al.  Establishing a Global Vaccine-Development Fund. , 2015, The New England journal of medicine.

[29]  T. Shimabukuro,et al.  Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013. , 2015, Vaccine.

[30]  S. Halperin,et al.  The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases. , 2014, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[31]  Ian Smith,et al.  Decline in mortality with the Belize Integrated Patient-Centred Country Wide Health Information System (BHIS) with Embedded Program Management , 2013, Int. J. Medical Informatics.

[32]  Ashley Shelby,et al.  Story and science , 2013, Human vaccines & immunotherapeutics.

[33]  W. Edmunds,et al.  The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment , 2013, PloS one.

[34]  F. Baylis,et al.  Ill-informed consent? A content analysis of physical risk disclosure in school-based HPV vaccine programs. , 2012, Public health nursing.